In the 1900s, companies in India turned to fine artists to channel their creativity and give their brand its identity with a unique logo We live in an era where a company’s logo is an integral part of ...

IN the next two weeks, I will be moderating in an event organized by the Philippine Business for Environmental Stewardship; our roundtable discussion will focus on "Building Resilient Communities ...

Students from three Greater Cincinnati high schools are teaming up to make a difference in the fight against cancer.The “Eastside Alliance” is made up of students from Anderson High School ...

Well, now a Transparent Display is available at various locations around Tokyo, which aims to simplify communication across language and disability barriers. The Tokyo Metropolitan Government (TMG ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

1Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, New York. 2Black Family Stem Cell Institute, Institute for Regenerative Medicine, Icahn School of ...

EXCLUSIVE: Sean Baker’s latest Anora has won Best Picture at this year’s Online Film Critics Society Awards. Scroll down for the full list of winners. Anora also won Best Actress for star ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

Public-health officials, activists, tech executives and others press everyday Americans to let “experts” and “authorities” control decisions that affect all of society. Technology allows ...

In a paper published today in Science Immunology, the team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML).